191 related articles for article (PubMed ID: 37895013)
1. AZD-7648, a DNA-PK Inhibitor, Induces DNA Damage, Apoptosis, and Cell Cycle Arrest in Chronic and Acute Myeloid Leukemia Cells.
Lapa BS; Costa MI; Figueiredo D; Jorge J; Alves R; Monteiro AR; Serambeque B; Laranjo M; Botelho MF; Carreira IM; Sarmento-Ribeiro AB; Gonçalves AC
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895013
[TBL] [Abstract][Full Text] [Related]
2. Wee1 promotes cell proliferation and imatinib resistance in chronic myeloid leukemia via regulating DNA damage repair dependent on ATM-γH2AX-MDC1.
Zeng F; Peng Y; Qin Y; Wang J; Jiang G; Feng W; Yuan Y
Cell Commun Signal; 2022 Dec; 20(1):199. PubMed ID: 36575478
[TBL] [Abstract][Full Text] [Related]
3. DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia.
Haines E; Nishida Y; Carr MI; Montoya RH; Ostermann LB; Zhang W; Zenke FT; Blaukat A; Andreeff M; Vassilev LT
Sci Rep; 2021 Jun; 11(1):12148. PubMed ID: 34108527
[TBL] [Abstract][Full Text] [Related]
4. DNA-dependent protein kinase: effect on DSB repair, G2/M checkpoint and mode of cell death in NSCLC cell lines.
Sak A; Groneberg M; Stuschke M
Int J Radiat Biol; 2019 Sep; 95(9):1205-1219. PubMed ID: 31287365
[No Abstract] [Full Text] [Related]
5. Increase of DNA damage and alteration of the DNA damage response in myelodysplastic syndromes and acute myeloid leukemias.
Popp HD; Naumann N; Brendel S; Henzler T; Weiss C; Hofmann WK; Fabarius A
Leuk Res; 2017 Jun; 57():112-118. PubMed ID: 28359030
[TBL] [Abstract][Full Text] [Related]
6. 5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia.
Schmelz K; Wagner M; Dörken B; Tamm I
Int J Cancer; 2005 May; 114(5):683-95. PubMed ID: 15609309
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target.
Lapa B; Gonçalves AC; Jorge J; Alves R; Pires AS; Abrantes AM; Coucelo M; Abrunhosa A; Botelho MF; Nascimento-Costa JM; Sarmento-Ribeiro AB
Med Oncol; 2020 Jul; 37(8):72. PubMed ID: 32725458
[TBL] [Abstract][Full Text] [Related]
8. Suppression of DNMT1 combined with ATM or ATR inhibitor as a therapeutic combination of acute myeloid leukemia.
Liu L; Hu X; Feng J; Lei A; Huang S; Liu X; Liu H; Luo L; Yao W
Anticancer Drugs; 2024 Mar; 35(3):251-262. PubMed ID: 38164802
[TBL] [Abstract][Full Text] [Related]
9. Survivin safeguards chromosome numbers and protects from aneuploidy independently from p53.
Wiedemuth R; Klink B; Töpfer K; Schröck E; Schackert G; Tatsuka M; Temme A
Mol Cancer; 2014 May; 13():107. PubMed ID: 24886358
[TBL] [Abstract][Full Text] [Related]
10. Activation of DNA damage repair pathways in response to nitrogen mustard-induced DNA damage and toxicity in skin keratinocytes.
Inturi S; Tewari-Singh N; Agarwal C; White CW; Agarwal R
Mutat Res; 2014; 763-764():53-63. PubMed ID: 24732344
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of DNA-dependent protein kinase induces accelerated senescence in irradiated human cancer cells.
Azad A; Jackson S; Cullinane C; Natoli A; Neilsen PM; Callen DF; Maira SM; Hackl W; McArthur GA; Solomon B
Mol Cancer Res; 2011 Dec; 9(12):1696-707. PubMed ID: 22009179
[TBL] [Abstract][Full Text] [Related]
12. Pleiotropic effects of spongean alkaloids on mechanisms of cell death, cell cycle progression and DNA damage response (DDR) of acute myeloid leukemia (AML) cells.
Stuhldreier F; Kassel S; Schumacher L; Wesselborg S; Proksch P; Fritz G
Cancer Lett; 2015 May; 361(1):39-48. PubMed ID: 25697484
[TBL] [Abstract][Full Text] [Related]
13. Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia.
Al-Aamri HM; Ku H; Irving HR; Tucci J; Meehan-Andrews T; Bradley C
BMC Cancer; 2019 Feb; 19(1):179. PubMed ID: 30813936
[TBL] [Abstract][Full Text] [Related]
14. DNA-PK Inhibitor, M3814, as a New Combination Partner of Mylotarg in the Treatment of Acute Myeloid Leukemia.
Carr MI; Zimmermann A; Chiu LY; Zenke FT; Blaukat A; Vassilev LT
Front Oncol; 2020; 10():127. PubMed ID: 32117773
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of diacylglycerol kinase zeta (DGKZ) induces apoptosis and G2/M phase arrest in human acute myeloid leukemia HL-60 cells through MAPK/survivin/caspase pathway.
Li H; Dong C; Tian Y; Li X; Wang B; Zhai D; Bai Y; Chao X
Pharmazie; 2019 Jul; 74(7):418-422. PubMed ID: 31288898
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Implications of p53 Status on Cancer Cell Fate Following Exposure to Ionizing Radiation and the DNA-PK Inhibitor M3814.
Sun Q; Guo Y; Liu X; Czauderna F; Carr MI; Zenke FT; Blaukat A; Vassilev LT
Mol Cancer Res; 2019 Dec; 17(12):2457-2468. PubMed ID: 31551253
[TBL] [Abstract][Full Text] [Related]
17. DNA-PKcs inhibition sensitizes cancer cells to carbon-ion irradiation via telomere capping disruption.
Zhou X; Zhang X; Xie Y; Tanaka K; Wang B; Zhang H
PLoS One; 2013; 8(8):e72641. PubMed ID: 24013362
[TBL] [Abstract][Full Text] [Related]
18. The DNA double-strand break response is abnormal in myeloblasts from patients with therapy-related acute myeloid leukemia.
Jacoby MA; De Jesus Pizarro RE; Shao J; Koboldt DC; Fulton RS; Zhou G; Wilson RK; Walter MJ
Leukemia; 2014 Jun; 28(6):1242-51. PubMed ID: 24304937
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting DNA-PKcs in a non-homologous end-joining pathway in response to DNA double-strand breaks.
Dong J; Zhang T; Ren Y; Wang Z; Ling CC; He F; Li GC; Wang C; Wen B
Oncotarget; 2017 Apr; 8(14):22662-22673. PubMed ID: 28186989
[TBL] [Abstract][Full Text] [Related]
20. The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR.
Zhou L; Chen S; Zhang Y; Kmieciak M; Leng Y; Li L; Lin H; Rizzo KA; Dumur CI; Ferreira-Gonzalez A; Rahmani M; Povirk L; Chalasani S; Berger AJ; Dai Y; Grant S
Blood; 2016 May; 127(18):2219-30. PubMed ID: 26851293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
